Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent TaxesGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxNon-Current AssetsNon-Current Deffered RevenueOther Accumulated ExpensesOther Non-Current AssetsPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShares OutstandingTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Iradimed (IRMD) Current Deferred Tax Assets (2016)

Iradimed has reported Current Deferred Tax Assets over the past 4 years, most recently at -$311871.0 for Q4 2016.

  • Quarterly Current Deferred Tax Assets fell 320.49% to -$311871.0 in Q4 2016 from the year-ago period, while the trailing twelve-month figure was -$311871.0 through Dec 2016, down 320.49% year-over-year, with the annual reading at -$311871.0 for FY2016, 320.49% down from the prior year.
  • Current Deferred Tax Assets was -$311871.0 for Q4 2016 at Iradimed, down from $317709.0 in the prior quarter.
  • Over five years, Current Deferred Tax Assets peaked at $338634.0 in Q1 2016 and troughed at -$311871.0 in Q4 2016.
  • The 4-year median for Current Deferred Tax Assets is $144930.5 (2015), against an average of $137450.8.
  • Year-over-year, Current Deferred Tax Assets skyrocketed 215.69% in 2015 and then plummeted 320.49% in 2016.
  • A 4-year view of Current Deferred Tax Assets shows it stood at $65961.0 in 2013, then soared by 76.38% to $116339.0 in 2014, then rose by 21.58% to $141446.0 in 2015, then plummeted by 320.49% to -$311871.0 in 2016.
  • Per Business Quant, the three most recent readings for IRMD's Current Deferred Tax Assets are -$311871.0 (Q4 2016), $317709.0 (Q3 2016), and $320587.0 (Q2 2016).